Franklin Resources Inc Kiniksa Pharmaceuticals, Ltd. Transaction History

Franklin Resources Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$17.63 - $21.74 $657,299 - $810,532	37,283 Added 139.39%	64,031 $1.26 Million
Q4 2023 Feb 09, 2024	BUY	$14.37 - $19.07 $1,379 - $1,830	96 Added 0.36%	26,748 $469,000
Q3 2023 Nov 13, 2023	SELL	$13.62 - $20.2 $33,396 - $49,530	-2,452 Reduced 8.42%	26,652 $462,000
Q2 2023 Aug 11, 2023	BUY	$10.44 - $16.48 $303,845 - $479,633	29,104 New	29,104 $409,000

1.95M

Ticker KNSA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 34,470,400
Market Cap $687M
Description
Kiniksa Pharmaceuticals, Ltd., a biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical needs worldwide. Its product candidates include ARCALYST, an interleukin-1alpha and interleukin-1beta, for the treatm...

Get notified when there are updates to the investment portfolio of Franklin Resources Inc, based on Form 13F filings with the SEC.

Stay updated on Franklin Resources Inc with notifications on news.